1998
DOI: 10.1002/(sici)1096-8628(19981204)80:4<385::aid-ajmg15>3.0.co;2-9
|View full text |Cite
|
Sign up to set email alerts
|

Angelman syndrome: Are the estimates too low?

Abstract: More than 300 cases of Angelman Syndrome (AS) have been reported. AS is still considered a clinical diagnosis because only approximately 80% of those individuals who meet the clinical criteria will have a maternal deletion of chromosome 15q11-13. Of the reported cases of AS, very few are of adults with AS. We present our findings on 11 adults with AS identified in a long-term residential care facility for persons with severe developmental disabilities. The diagnosis of AS was not recognized at the time of thei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
55
0
1

Year Published

1999
1999
2014
2014

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 79 publications
(60 citation statements)
references
References 14 publications
(18 reference statements)
2
55
0
1
Order By: Relevance
“…Angelman syndrome is a rare neurodevelopmental disorder first described in 1965 (Angelman, 1965) with a current prevalence estimate of 1 in 40,000 live births (Buckley, Dinno, & Weber, 1998;Clayton-Smith, 1993). It is caused by a disruption of the maternally inherited portion of chromosome 15q 11-13 (Clayton- Smith & Laan, 2003;Knoll, Nicholls, & Lalande, 1989) via four known genetic mechanisms (Jiang, Lev-Lehman, Bressler, Tsai, & Beadet, 1999;Lossie et al, 2001).…”
mentioning
confidence: 99%
“…Angelman syndrome is a rare neurodevelopmental disorder first described in 1965 (Angelman, 1965) with a current prevalence estimate of 1 in 40,000 live births (Buckley, Dinno, & Weber, 1998;Clayton-Smith, 1993). It is caused by a disruption of the maternally inherited portion of chromosome 15q 11-13 (Clayton- Smith & Laan, 2003;Knoll, Nicholls, & Lalande, 1989) via four known genetic mechanisms (Jiang, Lev-Lehman, Bressler, Tsai, & Beadet, 1999;Lossie et al, 2001).…”
mentioning
confidence: 99%
“…3 In recent years clearer delineation of the clinical phenotype of Angelman syndrome and improved diagnostic testing has led to improved recognition of the condition and the incidence of Angelman syndrome is now estimated to be between 1 in 10 000 and 1 in 40 000. [4][5][6][7] Studies of the specific cognitive and behavioural features associated with AS 8 and of the seizure disorder have improved management of the condition and provided insight into the long term outlook for affected patients. Molecular genetic studies have begun to elucidate the role of genes within the 15q11-13 region in the pathophysiology of Angelman syndrome 9 and have also shed light on the more general phenomenon of genomic imprinting.…”
mentioning
confidence: 99%
“…For AS the prevalence ranges from 1 in 20,000 in the United States (Buckley et al, 1998) to 1 in 12,000 in Sweden (Steffenburg et al, 1996). According to our study and to known natality, we estimate the minimal live birth prevalence for Slovakian population to 1 in 20,000 for PWS and to 1 in 40,000 for AS; showing that AS is 2 times less frequent than PWS.…”
Section: Discusionmentioning
confidence: 93%